BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1860265)

  • 41. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
    Opastirakul S; Chartapisak W
    J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclosporin A in the treatment of childhood glomerulonephritis.
    James RW; Burke JR; Petrie JJ; Rigby RJ; Williams M
    Aust N Z J Med; 1989 Jun; 19(3):198-201. PubMed ID: 2775040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood.
    Hulton SA; Neuhaus TJ; Dillon MJ; Barratt TM
    Pediatr Nephrol; 1994 Aug; 8(4):401-3. PubMed ID: 7947023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cyclosporin A for treatment in nephrotic syndrome of childhood--a preliminary report].
    Law KL; Lin HY; Lian JD; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):255-60. PubMed ID: 1646675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome.
    Melocoton TL; Kamil ES; Cohen AH; Fine RN
    Am J Kidney Dis; 1991 Nov; 18(5):583-8. PubMed ID: 1951339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome.
    Iijima K; Hamahira K; Tanaka R; Kobayashi A; Nozu K; Nakamura H; Yoshikawa N
    Kidney Int; 2002 May; 61(5):1801-5. PubMed ID: 11967030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome.
    Borel JF
    Clin Nephrol; 1991; 35 Suppl 1():S23-30. PubMed ID: 1860262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of cyclosporin A in adult nephrotic syndrome: nine cases and literature review.
    Green A; O'Meara Y; Sheehan J; Carmody M; Doyle G; Donohoe J
    Ir J Med Sci; 1990 Jun; 159(6):178-81. PubMed ID: 2228527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ciclosporin in idiopathic nephrotic syndrome of children.
    Brodehl J; Hoyer PF
    Am J Nephrol; 1989; 9 Suppl 1():61-4. PubMed ID: 2923148
    [No Abstract]   [Full Text] [Related]  

  • 51. Cyclosporin-associated nephropathy in patients with autoimmune diseases.
    Mihatsch MJ; Bach JF; Coovadia HM; Førre O; Moutsopoulos HM; Drosos AA; Siamopoulos KC; Noël LH; Ramsaroop R; Hällgren R
    Klin Wochenschr; 1988 Jan; 66(2):43-7. PubMed ID: 3347004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclosporin in frequently relapsing minimal change nephrotic syndrome.
    Hoyer PF; Krull F; Brodehl J
    Lancet; 1986 Aug; 2(8502):335. PubMed ID: 2874338
    [No Abstract]   [Full Text] [Related]  

  • 53. [Cyclosporine and idiopathic extramembranous glomerulopathy. Hypothesis, facts and questions in 1992].
    Rostoker G
    Nephrologie; 1992; 13(5):207-13. PubMed ID: 1470295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.
    Brodehl J
    Eur J Pediatr; 1991 Apr; 150(6):380-7. PubMed ID: 2040345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Drug treatment of chronic glomerulonephritis: pro].
    Kühn K; Brodehl J; Koch KM; Helmchen U
    Klin Wochenschr; 1985 Sep; 63(18):967-77. PubMed ID: 3903340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nephrotoxicity of cyclosporin A in humans: effects on glomerular filtration and tubular reabsorption rates.
    Dieperink H; Leyssac PP; Kemp E; Starklint H; Frandsen NE; Tvede N; Møller J; Buchler Frederiksen P; Rossing N
    Eur J Clin Invest; 1987 Dec; 17(6):493-6. PubMed ID: 3123248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome.
    Niaudet P
    Clin J Am Soc Nephrol; 2009 Oct; 4(10):1547-8. PubMed ID: 19808239
    [No Abstract]   [Full Text] [Related]  

  • 58. [Lipoid nephrosis in children. Development and anatomo-clinical correlation].
    Rodríguez E; Villarroel A; Delucchi A; Cano F; Rosenberg H; Puga F
    Rev Chil Pediatr; 1990; 61(3):139-42. PubMed ID: 2077585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporin A: action and side-effects.
    Mihatsch MJ; Thiel G; Ryffel B
    Toxicol Lett; 1989 Mar; 46(1-3):125-39. PubMed ID: 2650019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal function and blood pressure in patients treated with cyclosporin A for uveitis.
    Deray G; Le Hoang P; Cacoub P; Aupetit B; Mertani A; Martinez F; Rottembourg J
    Eur J Clin Pharmacol; 1988; 34(6):601-4. PubMed ID: 3169111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.